Vasculitis & polymyalgia rheumatica

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis

Arthritis Res TherPublished Diagnostic accuracy study

Authors' conclusion

The IMT is higher in LV-GCA than in atherosclerosis. The proposed US halo count achieves an accuracy of > 95% for the differential diagnosis between LV-GCA and atherosclerosis.

Study context

Population
Patients with large vessel giant cell arteritis (LV-GCA) and patients with high-risk atherosclerosis; Ultrasound (US) of axillary, subclavian and common carotid arteries (intima-media thickness (IMT) ≥ 1 mm pathological)
Participants
44 vs 42
Comparison
LV-GCA vs high-risk atherosclerosis, US IMT of axillary, subclavian and common carotid arteries (CCA)
  • LV-GCAn = 44
  • Atherosclerosisn = 42reference
Outcome
Diagnostic discriminant validity of US IMT between LV-GCA and atherosclerosis

Performance

As reported in the abstract

US halo count (IMT ≥ 1 mm) for GCA diagnosis
  • Cutoff >1 pathological vessel in the summative count of axillary and subclavian arteries, or ≥3 of six vessels including CCA: precision upper 95% for GCA diagnosis
  • Mean IMT of all arteries significantly higher in LV-GCA than in atherosclerosis

Further findings

Axillary IMT ≥ 1 mm — LV-GCA
31 events
Subclavian IMT ≥ 1 mm — LV-GCA
30 events
CCA IMT ≥ 1 mm — LV-GCA
28 events
CCA IMT ≥ 1 mm — Atherosclerosis: carotid distal involvement
14
CCA IMT ≥ 1 mm — Atherosclerosis: carotid distal involvement, bilateral
5
CCA IMT ≥ 1 mm — Atherosclerosis: isolated carotid proximal involvement
1

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis. Arthritis Res Ther. Published 14 February 2023. doi:10.1186/s13075-023-03002-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.